Eisai & Genomics Plc Collaborate
News Apr 13, 2015
Eisai Co., Ltd. and Genomics plc have entered into a collaborative agreement to use Genomics' sophisticated statistical analyses of large-scale multi-phenotype genetic association data to inform Eisai's drug discovery process, including target selection, target validation, indication selection and repositioning.
Both companies believe that human genetics and genomics can add great value to the drug development process. Genomics, the Oxford based genome analytics company, will be partnering with Eisai's new Integrated Human Genomics (IHGx) Research Unit which operates directly under the supervision of Eisai Product Creation Systems' Chief Clinical Officer.
“Eisai is delighted to be working with Genomics,” states Dr. Nadeem Sarwar, Director of the IHGx Research Unit, “Genomics' founders are internationally recognized leaders in the analysis and interpretation of human genetic data. This collaboration is another indication of Eisai's commitment to leveraging genomic knowledge to accelerate the discovery and development of impactful new medicines.”
Professor Peter Donnelly, a director and founder of Genomics, says, “Genomics' research work with Eisai will demonstrate the real value that powerful analyses of large genomic databases can add to drug development pipelines.”
“Genomics is excited to be working with one of the world's leading research and development-based pharmaceutical companies in the rapidly growing area of genomic analysis. This exciting new area promises to potentially make a positive difference to medicine,” adds John Colenutt, CEO of Genomics.
Early Life-Changing Experiences Also Change Your GenesNews
Factors in early life such as maternal care influence the number and modifications of certain 'jumping genes' - a finding that ties together nature and nurture.READ MORE
Genetic Identity of Atacama "Alien" Skeleton RevealedNews
A mysterious six-inch skeleton found in the Chilean desert was thought to be the answer to extraterrestrial life. Instead, it may provide solutions to some very human questions about mutation.READ MORE